Tokyo University of Science · Faculty of Pharmaceutical Sciences · 教授

Research keywordsレギュラトリーサイエンス・医薬品等のレギュラトリーサイエンス ファーマコビジランス

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• The Use of Subgroup Disproportionality Analyses to Explore the Sensitivity of a Global Database of Individual Case Safety Reports to Known Pharmacogenomic Risk Variants Common in Japan.
• Interstitial Lung Disease as an Adverse Drug Reaction in Japan: Exploration of Regulatory Actions as a Basis for High Reporting.
• A In vivo CAR T cells and targeted gene delivery: A theme for the Pharmaceuticals and Medical Devices Agency Science Board to address
• PMDA’s vision for Horizon Scanning of emerging technologies potentially relevant to the development of new medical products: regulatory challenge.

• Official profile